Is bone density associated with cognitive function in postmenopausal women?;Knochendichte mit bezug zur kognitiven leistung im alter: Sonographische knochendichte- und kognitions-kurztest-Ergebnisse bei 362 seniorinnen

Geburtshilfe und Frauenheilkunde

Volumn 62, Issue 1, 2002, Pages 30-36

  Wenderlein, J M ^a   Hengstler, S ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; ESTROGEN DEFICIENCY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID STORAGE; LOCOMOTION; OSTEOPOROSIS; PATIENT COUNSELING; POSTMENOPAUSE; SOCIAL BEHAVIOR;

EID: 0036171439     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20279     Document Type: Article

References (42)

1. APOE genotype influences functional status among elderly without dementia
2. Weight loss precedes dementia in community-dwelling older adults
3. Ovarielle Steroidhormone und Anti-Östrogene: Risiken zu und Prävention in der Karzinogenese der Mamma und des Endometriums in der Postmenopause
4. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics
5. Das Klimakterium: Endokrinologie, Pharmakologie der Hormone und Hormonsubstitution
6. Hormonsubstitution in der Postmenopause und die Wahl des Gestagens
7. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females
8. Association of waking episodes with menopausal flushes
9. Oestrogen and the cholinergic hypothesis: Implications for oestrogen replacement therapy in postmenopausal women
10. Estrogen and cerebral blood flow: A mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease
11. Knochendichte bei Patientinnen mit Mammakarzinom im Vergleich zu gesunden matched-pair-Kontrollen
12. Estrogen replacement therapy in older women. Comparisons between Alzheimer's diseas cases and mondemented control subjects
13. Human sleep, sleep loss and behaviour: Implications for the prefrontal cortex and psychiatric disorder
14. Entwicklung und Validierung eines Tests zur Früherkennung der Demenz mit Depressionsabgrenzung (TFDD)
15. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein
16. A population-based study on the association between dementia and hip fracture
17. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging
18. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women
19. Epidemiology of dementia in Rochester, Minnesota
20. Weight change between age 50 years and old age is associated with risk of hip fracture in white women aged 67 years and older
21. Hormone replacement therapy and cognition: Systematic review and meta-analysis
22. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women
23. Fracture risk in patients with Alzheimer's disease
24. Bone mineral density in women with depression
25. Estrogen effects of the synaptology and neural membranes of the rat hypothalamus arcuate nucleus
26. Memory functioning at menopause; Impact of age in ovariectomized women
27. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type
28. Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass
29. Validity of the trail making test as an indicator of organic brain damage
30. Understanding the role of estrogen on cognition and dementia
31. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
32. "Add-Back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri
33. Low lumbar bone mineral density in patients with major depression
34. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
35. The Modified Mini-Mental State (3 MS) examination
36. Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-beta and inflammatory reaction
37. Osteoporoseprävention kann sich postmenopausal an Fettdepots orientieren
38. Östrogensubstitution postmenopausal und Cerebral-funktionen
39. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
40. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women
41. Association between bone mineral density and cognitive decline in older women